By using a game theoretical approach and the notion of "forum" or "regime shifting" this paper examines the multiple interfaces of the multinational pharmaceutical corporations (MNPCs) with their major counterparts at home and abroad, including the governments of the North and South, the...

The Complete Treatment Pack (COMPACK) program is a medicine access program designed to reach the poorest of the poor with complete treatment regimens for the top most common diseases in the country. The program aims to address the increasing morbidity and mortality due to these common diseases...

The recent reform of the U.S. health care system has been described both as a boon and a death blow for the healthcare industry and for private insurers in particular. We exploit the surprise election of Republican Scott Brown to the U.S. Senate, which dealt a serious blow to the prospects for...

Over the years, many pharmaceutical companies have sought trademark protection for non-traditional aspects of their products. However, the potential consequences that could arise from granting such protection to pharmaceutical products have not received due attention from policy makers,...

In Helsinn Healthcare v. Teva Pharmaceuticals, the Supreme Court considers whether the term "on sale" in 35 U.S.C. § 102, which lays out the rules for prior art that prevents patenting of inventions, contemplates only sales or offers for sale that render the relevant invention available to the...

Problem de finition: The inventory control problem associated with the distribution of essential medicines in Zambia involves seasonality and uncertainty in both demand and lead-times, heterogeneous delivery locations, and lost sales. Beyond the traditional performance metrics of system service...